Thomas Christine E has filed 5 insider transactions across 1 company since October 2023.
Most recent transaction: a grant/award of 55090 shares of FEMASYS INC ($FEMY) on January 28, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2025 | FEMASYS INC | $FEMY | Thomas Christine E | Chief Reg & Clinical Officer | A | Stock Option (Right to Buy) | 55090 | $0.00 | 55,090.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | FEMASYS INC | $FEMY | Thomas Christine E | Chief Reg & Clinical Officer | A | Stock Option (Right to Buy) | 28682 | $0.00 | 28,682.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | FEMASYS INC | $FEMY | Thomas Christine E | Chief Reg & Clinical Officer | A | Stock Option (Right to Buy) | 23600 | $0.00 | 23,600.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | FEMASYS INC | $FEMY | Thomas Christine E | SVP, Regulatory & Clinical | A | Stock Option (Right to Buy) | 32600 | $0.00 | 32,600.0000 | 0 | 9999.99% | 0.00% |
| Oct. 10, 2023 | FEMASYS INC | $FEMY | Thomas Christine E | SVP, Regulatory & Clinical | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |